Eichler HG - Search Results

1

Regulatory watch: Where do new medicines originate from in the EU?

Lincker H, Ziogas C, Carr M, Porta N, Eichler HG. Lincker H, et al. Among authors: eichler hg. Nat Rev Drug Discov. 2014 Feb;13(2):92-3. doi: 10.1038/nrd4232. Nat Rev Drug Discov. 2014. PMID: 24481298 No abstract available.

2

The Innovative Medicines Initiative: an engine for regulatory science.

Goldman M, Seigneuret N, Eichler HG. Goldman M, et al. Among authors: eichler hg. Nat Rev Drug Discov. 2015 Jan;14(1):1-2. doi: 10.1038/nrd4520. Epub 2014 Dec 12. Nat Rev Drug Discov. 2015. PMID: 25503331

3

European regulatory experience with drugs for central nervous system disorders.

Butlen-Ducuing F, Zienowicz M, Pétavy F, Haas M, Salmonson T, Eichler HG, Rasi G. Butlen-Ducuing F, et al. Among authors: eichler hg. Nat Rev Drug Discov. 2015 Feb;14(2):89-90. doi: 10.1038/nrd4511. Epub 2014 Dec 19. Nat Rev Drug Discov. 2015. PMID: 25524018 No abstract available.

4

Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma.

Eichler HG, Pignatti F, Flamion B, Leufkens H, Breckenridge A. Eichler HG, et al. Nat Rev Drug Discov. 2008 Oct;7(10):818-26. doi: 10.1038/nrd2664. Epub 2008 Sep 12. Nat Rev Drug Discov. 2008. PMID: 18787530 Review.

5

Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers.

Eichler HG, Bloechl-Daum B, Abadie E, Barnett D, König F, Pearson S. Eichler HG, et al. Nat Rev Drug Discov. 2010 Apr;9(4):277-91. doi: 10.1038/nrd3079. Epub 2010 Feb 26. Nat Rev Drug Discov. 2010. PMID: 20186141 Review.

6

New drug approval success rate in Europe in 2009.

Eichler HG, Aronsson B, Abadie E, Salmonson T. Eichler HG, et al. Nat Rev Drug Discov. 2010 May;9(5):355-6. doi: 10.1038/nrd3169. Nat Rev Drug Discov. 2010. PMID: 20431561 No abstract available.

7

The risks of risk aversion in drug regulation.

Eichler HG, Bloechl-Daum B, Brasseur D, Breckenridge A, Leufkens H, Raine J, Salmonson T, Schneider CK, Rasi G. Eichler HG, et al. Nat Rev Drug Discov. 2013 Dec;12(12):907-16. doi: 10.1038/nrd4129. Epub 2013 Nov 15. Nat Rev Drug Discov. 2013. PMID: 24232377 Review.

8

The evolution of adaptiveness: balancing speed and evidence.

Eichler HG, Barker R, Bedlington N, Bouvy JC, Broekmans AW, Bucsics A, Cerreta F, Corriol-Rohou S, Granados A, Le Cam Y, Schuurman A. Eichler HG, et al. Nat Rev Drug Discov. 2018 Dec;17(12):845-846. doi: 10.1038/nrd.2018.90. Epub 2018 Jul 6. Nat Rev Drug Discov. 2018. PMID: 29977052 No abstract available.

9

Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug response.

Eichler HG, Abadie E, Breckenridge A, Flamion B, Gustafsson LL, Leufkens H, Rowland M, Schneider CK, Bloechl-Daum B. Eichler HG, et al. Nat Rev Drug Discov. 2011 Jul 1;10(7):495-506. doi: 10.1038/nrd3501. Nat Rev Drug Discov. 2011. PMID: 21720406 Review.

10

Precision medicine and the changing role of regulatory agencies.

Breckenridge A, Eichler HG, Jarow JP. Breckenridge A, et al. Among authors: eichler hg. Nat Rev Drug Discov. 2016 Dec;15(12):805-806. doi: 10.1038/nrd.2016.206. Epub 2016 Oct 14. Nat Rev Drug Discov. 2016. PMID: 27739512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters